お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、ポロキサマーの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にポロキサマー市場を分類しています。
本レポートでは世界のポロキサマー市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：BASF、Croda、Hubei Hengshuo、ADEKA、Solvay、Lakeland Chemicals、Nanjing Well、Merck KGaA

レポートはポロキサマーの主要生産者を調査し、主要地域や国の消費状況も提供します。ポロキサマーの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Poloxamer 124
    Poloxamer 188
    Poloxamer 338
    Poloxamer 407
    Poloxamer 184
    Others

用途別の市場セグメント：
    Pharmaceutical Industry
    Cosmetics Industry
    Biologics
    Others

本レポートの詳細内容
本レポートは、世界のポロキサマー市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてポロキサマー市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）のポロキサマー生産量、成長率、市場シェアを調査している。

二. 消費面では、ポロキサマーの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのポロキサマー売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のポロキサマー市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ポロキサマーのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：ポロキサマーのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： ポロキサマーの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおけるポロキサマーの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章ポロキサマーメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：ポロキサマーの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：ポロキサマーの主要メーカーの概要を提供し、製品の説明と仕様、ポロキサマーの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ポロキサマーの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)).

The global Poloxamer market is projected to grow from US$ 244 million in 2024 to US$ 291 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.0% during the forecast period.
Global major companies profiled in the Poloxamer market include BASF, Croda, etc. Global top two companies account for about 65% of the market share.  North America and Asia Pacific are likely to offer good prospects, the sum of the two market shares is about 70%.  In terms of product, Poloxamer 407 is the largest segment, with a share of nearly 30%. And according to the application, the largest application is Pharmaceutical Industry, followed by Cosmetics Industry, Biologics, etc.
The poloxamer market is growing steadily, driven by its versatile applications across pharmaceuticals, cosmetics, and personal care industries. Poloxamers, known for their surfactant, emulsifying, and solubilizing properties, are widely used in drug delivery systems, topical formulations, and oral care products. The pharmaceutical sector, in particular, is boosting demand due to the increasing focus on controlled-release and targeted drug delivery. In cosmetics, poloxamers are popular in formulations for their gentle cleansing and conditioning benefits. The market is further influenced by advancements in biotechnology and the growing demand for biocompatible and non-toxic ingredients. However, fluctuations in raw material prices and regulatory scrutiny over synthetic ingredients in personal care products could impact market dynamics.
In terms of production side, this report researches the Poloxamer production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Poloxamer by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for Poloxamer, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Poloxamer, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Poloxamer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Poloxamer sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Poloxamer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Poloxamer sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BASF, Croda, Hubei Hengshuo, ADEKA, Solvay, Lakeland Chemicals, Nanjing Well, Merck KGaA, etc.

Market Segmentation
By Company
    BASF
    Croda
    Hubei Hengshuo
    ADEKA
    Solvay
    Lakeland Chemicals
    Nanjing Well
    Merck KGaA

Segment by Type
    Poloxamer 124
    Poloxamer 188
    Poloxamer 338
    Poloxamer 407
    Poloxamer 184
    Others

Segment by Application
    Pharmaceutical Industry
    Cosmetics Industry
    Biologics
    Others

Production by Region
    North America
    Europe
    China
    Japan

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Poloxamer production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Poloxamer in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Poloxamer manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poloxamer sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

List of Tables
 Table 1. Global Poloxamer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Key Manufacturers of Poloxamer 124
 Table 3. Key Manufacturers of Poloxamer 188
 Table 4. Key Manufacturers of Poloxamer 338
 Table 5. Key Manufacturers of Poloxamer 407
 Table 6. Key Manufacturers of Poloxamer 184
 Table 7. Key Manufacturers of Others
 Table 8. Global Poloxamer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. Global Poloxamer Production Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Kilotons)
 Table 10. Global Poloxamer Production by Region (2019-2024) & (Kilotons)
 Table 11. Global Poloxamer Production by Region (2025-2030) & (Kilotons)
 Table 12. Global Poloxamer Production Market Share by Region (2019-2024)
 Table 13. Global Poloxamer Production Market Share by Region (2025-2030)
 Table 14. Global Poloxamer Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 15. Global Poloxamer Revenue by Region (2019-2024) & (US$ Million)
 Table 16. Global Poloxamer Revenue by Region (2025-2030) & (US$ Million)
 Table 17. Global Poloxamer Revenue Market Share by Region (2019-2024)
 Table 18. Global Poloxamer Revenue Market Share by Region (2025-2030)
 Table 19. Global Poloxamer Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Kilotons)
 Table 20. Global Poloxamer Sales by Region (2019-2024) & (Kilotons)
 Table 21. Global Poloxamer Sales by Region (2025-2030) & (Kilotons)
 Table 22. Global Poloxamer Sales Market Share by Region (2019-2024)
 Table 23. Global Poloxamer Sales Market Share by Region (2025-2030)
 Table 24. Global Poloxamer Sales by Manufacturers (2019-2024) & (Kilotons)
 Table 25. Global Poloxamer Sales Share by Manufacturers (2019-2024)
 Table 26. Global Poloxamer Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 27. Global Poloxamer Revenue Market Share by Manufacturers (2019-2024)
 Table 28. Poloxamer Price by Manufacturers (2019-2024) & (US$/Ton)
 Table 29. Global Key Players of Poloxamer, Industry Ranking, 2022 VS 2023
 Table 30. Global Poloxamer Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 31. Global Poloxamer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poloxamer as of 2023)
 Table 32. Global Key Manufacturers of Poloxamer, Manufacturing Base Distribution and Headquarters
 Table 33. Global Key Manufacturers of Poloxamer, Product Offered and Application
 Table 34. Global Key Manufacturers of Poloxamer, Date of Enter into This Industry
 Table 35. Mergers & Acquisitions, Expansion Plans
 Table 36. Global Poloxamer Sales by Type (2019-2024) & (Kilotons)
 Table 37. Global Poloxamer Sales by Type (2025-2030) & (Kilotons)
 Table 38. Global Poloxamer Sales Share by Type (2019-2024)
 Table 39. Global Poloxamer Sales Share by Type (2025-2030)
 Table 40. Global Poloxamer Revenue by Type (2019-2024) & (US$ Million)
 Table 41. Global Poloxamer Revenue by Type (2025-2030) & (US$ Million)
 Table 42. Global Poloxamer Revenue Share by Type (2019-2024)
 Table 43. Global Poloxamer Revenue Share by Type (2025-2030)
 Table 44. Poloxamer Price by Type (2019-2024) & (US$/Ton)
 Table 45. Global Poloxamer Price Forecast by Type (2025-2030) & (US$/Ton)
 Table 46. Global Poloxamer Sales by Application (2019-2024) & (Kilotons)
 Table 47. Global Poloxamer Sales by Application (2025-2030) & (Kilotons)
 Table 48. Global Poloxamer Sales Share by Application (2019-2024)
 Table 49. Global Poloxamer Sales Share by Application (2025-2030)
 Table 50. Global Poloxamer Revenue by Application (2019-2024) & (US$ Million)
 Table 51. Global Poloxamer Revenue by Application (2025-2030) & (US$ Million)
 Table 52. Global Poloxamer Revenue Share by Application (2019-2024)
 Table 53. Global Poloxamer Revenue Share by Application (2025-2030)
 Table 54. Poloxamer Price by Application (2019-2024) & (US$/Ton)
 Table 55. Global Poloxamer Price Forecast by Application (2025-2030) & (US$/Ton)
 Table 56. US & Canada Poloxamer Sales by Type (2019-2024) & (Kilotons)
 Table 57. US & Canada Poloxamer Sales by Type (2025-2030) & (Kilotons)
 Table 58. US & Canada Poloxamer Revenue by Type (2019-2024) & (US$ Million)
 Table 59. US & Canada Poloxamer Revenue by Type (2025-2030) & (US$ Million)
 Table 60. US & Canada Poloxamer Sales by Application (2019-2024) & (Kilotons)
 Table 61. US & Canada Poloxamer Sales by Application (2025-2030) & (Kilotons)
 Table 62. US & Canada Poloxamer Revenue by Application (2019-2024) & (US$ Million)
 Table 63. US & Canada Poloxamer Revenue by Application (2025-2030) & (US$ Million)
 Table 64. US & Canada Poloxamer Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 65. US & Canada Poloxamer Revenue by Country (2019-2024) & (US$ Million)
 Table 66. US & Canada Poloxamer Revenue by Country (2025-2030) & (US$ Million)
 Table 67. US & Canada Poloxamer Sales by Country (2019-2024) & (Kilotons)
 Table 68. US & Canada Poloxamer Sales by Country (2025-2030) & (Kilotons)
 Table 69. Europe Poloxamer Sales by Type (2019-2024) & (Kilotons)
 Table 70. Europe Poloxamer Sales by Type (2025-2030) & (Kilotons)
 Table 71. Europe Poloxamer Revenue by Type (2019-2024) & (US$ Million)
 Table 72. Europe Poloxamer Revenue by Type (2025-2030) & (US$ Million)
 Table 73. Europe Poloxamer Sales by Application (2019-2024) & (Kilotons)
 Table 74. Europe Poloxamer Sales by Application (2025-2030) & (Kilotons)
 Table 75. Europe Poloxamer Revenue by Application (2019-2024) & (US$ Million)
 Table 76. Europe Poloxamer Revenue by Application (2025-2030) & (US$ Million)
 Table 77. Europe Poloxamer Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 78. Europe Poloxamer Sales by Country (2019-2024) & (Kilotons)
 Table 79. Europe Poloxamer Sales by Country (2025-2030) & (Kilotons)
 Table 80. Europe Poloxamer Revenue by Country (2019-2024) & (US$ Million)
 Table 81. Europe Poloxamer Revenue by Country (2025-2030) & (US$ Million)
 Table 82. China Poloxamer Sales by Type (2019-2024) & (Kilotons)
 Table 83. China Poloxamer Sales by Type (2025-2030) & (Kilotons)
 Table 84. China Poloxamer Revenue by Type (2019-2024) & (US$ Million)
 Table 85. China Poloxamer Revenue by Type (2025-2030) & (US$ Million)
 Table 86. China Poloxamer Sales by Application (2019-2024) & (Kilotons)
 Table 87. China Poloxamer Sales by Application (2025-2030) & (Kilotons)
 Table 88. China Poloxamer Revenue by Application (2019-2024) & (US$ Million)
 Table 89. China Poloxamer Revenue by Application (2025-2030) & (US$ Million)
 Table 90. Asia Poloxamer Sales by Type (2019-2024) & (Kilotons)
 Table 91. Asia Poloxamer Sales by Type (2025-2030) & (Kilotons)
 Table 92. Asia Poloxamer Revenue by Type (2019-2024) & (US$ Million)
 Table 93. Asia Poloxamer Revenue by Type (2025-2030) & (US$ Million)
 Table 94. Asia Poloxamer Sales by Application (2019-2024) & (Kilotons)
 Table 95. Asia Poloxamer Sales by Application (2025-2030) & (Kilotons)
 Table 96. Asia Poloxamer Revenue by Application (2019-2024) & (US$ Million)
 Table 97. Asia Poloxamer Revenue by Application (2025-2030) & (US$ Million)
 Table 98. Asia Poloxamer Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 99. Asia Poloxamer Revenue by Region (2019-2024) & (US$ Million)
 Table 100. Asia Poloxamer Revenue by Region (2025-2030) & (US$ Million)
 Table 101. Asia Poloxamer Sales by Region (2019-2024) & (Kilotons)
 Table 102. Asia Poloxamer Sales by Region (2025-2030) & (Kilotons)
 Table 103. Middle East, Africa and Latin America Poloxamer Sales by Type (2019-2024) & (Kilotons)
 Table 104. Middle East, Africa and Latin America Poloxamer Sales by Type (2025-2030) & (Kilotons)
 Table 105. Middle East, Africa and Latin America Poloxamer Revenue by Type (2019-2024) & (US$ Million)
 Table 106. Middle East, Africa and Latin America Poloxamer Revenue by Type (2025-2030) & (US$ Million)
 Table 107. Middle East, Africa and Latin America Poloxamer Sales by Application (2019-2024) & (Kilotons)
 Table 108. Middle East, Africa and Latin America Poloxamer Sales by Application (2025-2030) & (Kilotons)
 Table 109. Middle East, Africa and Latin America Poloxamer Revenue by Application (2019-2024) & (US$ Million)
 Table 110. Middle East, Africa and Latin America Poloxamer Revenue by Application (2025-2030) & (US$ Million)
 Table 111. Middle East, Africa and Latin America Poloxamer Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 112. Middle East, Africa and Latin America Poloxamer Revenue by Country (2019-2024) & (US$ Million)
 Table 113. Middle East, Africa and Latin America Poloxamer Revenue by Country (2025-2030) & (US$ Million)
 Table 114. Middle East, Africa and Latin America Poloxamer Sales by Country (2019-2024) & (Kilotons)
 Table 115. Middle East, Africa and Latin America Poloxamer Sales by Country (2025-2030) & (Kilotons)
 Table 116. BASF Corporation Information
 Table 117. BASF Description and Major Businesses
 Table 118. BASF Poloxamer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 119. BASF Poloxamer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 120. BASF Recent Developments
 Table 121. Croda Corporation Information
 Table 122. Croda Description and Major Businesses
 Table 123. Croda Poloxamer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 124. Croda Poloxamer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 125. Croda Recent Developments
 Table 126. Hubei Hengshuo Corporation Information
 Table 127. Hubei Hengshuo Description and Major Businesses
 Table 128. Hubei Hengshuo Poloxamer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 129. Hubei Hengshuo Poloxamer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 130. Hubei Hengshuo Recent Developments
 Table 131. ADEKA Corporation Information
 Table 132. ADEKA Description and Major Businesses
 Table 133. ADEKA Poloxamer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 134. ADEKA Poloxamer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 135. ADEKA Recent Developments
 Table 136. Solvay Corporation Information
 Table 137. Solvay Description and Major Businesses
 Table 138. Solvay Poloxamer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 139. Solvay Poloxamer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 140. Solvay Recent Developments
 Table 141. Lakeland Chemicals Corporation Information
 Table 142. Lakeland Chemicals Description and Major Businesses
 Table 143. Lakeland Chemicals Poloxamer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 144. Lakeland Chemicals Poloxamer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 145. Lakeland Chemicals Recent Developments
 Table 146. Nanjing Well Corporation Information
 Table 147. Nanjing Well Description and Major Businesses
 Table 148. Nanjing Well Poloxamer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 149. Nanjing Well Poloxamer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 150. Nanjing Well Recent Developments
 Table 151. Merck KGaA Corporation Information
 Table 152. Merck KGaA Description and Major Businesses
 Table 153. Merck KGaA Poloxamer Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 154. Merck KGaA Poloxamer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 155. Merck KGaA Recent Developments
 Table 156. Key Raw Materials Lists
 Table 157. Raw Materials Key Suppliers Lists
 Table 158. Poloxamer Distributors List
 Table 159. Poloxamer Customers List
 Table 160. Poloxamer Market Trends
 Table 161. Poloxamer Market Drivers
 Table 162. Poloxamer Market Challenges
 Table 163. Poloxamer Market Restraints
 Table 164. Research Programs/Design for This Report
 Table 165. Key Data Information from Secondary Sources
 Table 166. Key Data Information from Primary Sources


List of Figures
 Figure 1. Poloxamer Product Picture
 Figure 2. Global Poloxamer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Poloxamer Market Share by Type: 2023 & 2030
 Figure 4. Poloxamer 124 Product Picture
 Figure 5. Poloxamer 188 Product Picture
 Figure 6. Poloxamer 338 Product Picture
 Figure 7. Poloxamer 407 Product Picture
 Figure 8. Poloxamer 184 Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Poloxamer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 11. Global Poloxamer Market Share by Application in 2024 & 2030
 Figure 12. Pharmaceutical Industry
 Figure 13. Cosmetics Industry
 Figure 14. Biologics
 Figure 15. Others
 Figure 16. Poloxamer Report Years Considered
 Figure 17. Global Poloxamer Capacity, Production and Utilization (2019-2030) & (Kilotons)
 Figure 18. Global Poloxamer Production by Region: 2019 VS 2023 VS 2030 (Kilotons)
 Figure 19. Global Poloxamer Production Market Share by Region in Percentage: 2023 Versus 2030
 Figure 20. Global Poloxamer Production Market Share by Region (2019-2030)
 Figure 21. Poloxamer Production Growth Rate in North America (2019-2030) & (Kilotons)
 Figure 22. Poloxamer Production Growth Rate in Europe (2019-2030) & (Kilotons)
 Figure 23. Poloxamer Production Growth Rate in China (2019-2030) & (Kilotons)
 Figure 24. Poloxamer Production Growth Rate in Japan (2019-2030) & (Kilotons)
 Figure 25. Global Poloxamer Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 26. Global Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 27. Global Poloxamer Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 28. Global Poloxamer Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 29. Global Poloxamer Revenue Market Share by Region (2019-2030)
 Figure 30. Global Poloxamer Sales (2019-2030) & (Kilotons)
 Figure 31. Global Poloxamer Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Kilotons)
 Figure 32. Global Poloxamer Sales Market Share by Region (2019-2030)
 Figure 33. US & Canada Poloxamer Sales YoY (2019-2030) & (Kilotons)
 Figure 34. US & Canada Poloxamer Revenue YoY (2019-2030) & (US$ Million)
 Figure 35. Europe Poloxamer Sales YoY (2019-2030) & (Kilotons)
 Figure 36. Europe Poloxamer Revenue YoY (2019-2030) & (US$ Million)
 Figure 37. China Poloxamer Sales YoY (2019-2030) & (Kilotons)
 Figure 38. China Poloxamer Revenue YoY (2019-2030) & (US$ Million)
 Figure 39. Asia (excluding China) Poloxamer Sales YoY (2019-2030) & (Kilotons)
 Figure 40. Asia (excluding China) Poloxamer Revenue YoY (2019-2030) & (US$ Million)
 Figure 41. Middle East, Africa and Latin America Poloxamer Sales YoY (2019-2030) & (Kilotons)
 Figure 42. Middle East, Africa and Latin America Poloxamer Revenue YoY (2019-2030) & (US$ Million)
 Figure 43. Global Poloxamer Sales Share by Manufacturers (2023)
 Figure 44. The Poloxamer Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 45. Global Poloxamer Revenue Share by Manufacturers (2023)
 Figure 46. The Top 5 and 10 Largest Manufacturers of Poloxamer in the World: Market Share by Poloxamer Revenue in 2023
 Figure 47. Global Poloxamer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 48. Global Poloxamer Sales Market Share by Type (2019-2030)
 Figure 49. Global Poloxamer Revenue Market Share by Type (2019-2030)
 Figure 50. Global Poloxamer Sales Market Share by Application (2019-2030)
 Figure 51. Global Poloxamer Revenue Market Share by Application (2019-2030)
 Figure 52. US & Canada Poloxamer Sales Market Share by Type (2019-2030)
 Figure 53. US & Canada Poloxamer Revenue Market Share by Type (2019-2030)
 Figure 54. US & Canada Poloxamer Sales Market Share by Application (2019-2030)
 Figure 55. US & Canada Poloxamer Revenue Market Share by Application (2019-2030)
 Figure 56. US & Canada Poloxamer Revenue Share by Country (2019-2030)
 Figure 57. US & Canada Poloxamer Sales Share by Country (2019-2030)
 Figure 58. US Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 59. Canada Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 60. Europe Poloxamer Sales Market Share by Type (2019-2030)
 Figure 61. Europe Poloxamer Revenue Market Share by Type (2019-2030)
 Figure 62. Europe Poloxamer Sales Market Share by Application (2019-2030)
 Figure 63. Europe Poloxamer Revenue Market Share by Application (2019-2030)
 Figure 64. Europe Poloxamer Sales Share by Country (2019-2030)
 Figure 65. Europe Poloxamer Revenue Share by Country (2019-2030)
 Figure 66. Germany Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 67. France Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 68. U.K. Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 69. Italy Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 70. Russia Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 71. China Poloxamer Sales Market Share by Type (2019-2030)
 Figure 72. China Poloxamer Revenue Market Share by Type (2019-2030)
 Figure 73. China Poloxamer Sales Market Share by Application (2019-2030)
 Figure 74. China Poloxamer Revenue Market Share by Application (2019-2030)
 Figure 75. Asia Poloxamer Sales Market Share by Type (2019-2030)
 Figure 76. Asia Poloxamer Revenue Market Share by Type (2019-2030)
 Figure 77. Asia Poloxamer Sales Market Share by Application (2019-2030)
 Figure 78. Asia Poloxamer Revenue Market Share by Application (2019-2030)
 Figure 79. Asia Poloxamer Revenue Share by Region (2019-2030)
 Figure 80. Asia Poloxamer Sales Share by Region (2019-2030)
 Figure 81. Japan Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 82. South Korea Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 83. China Taiwan Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 84. Southeast Asia Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 85. India Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 86. Middle East, Africa and Latin America Poloxamer Sales Market Share by Type (2019-2030)
 Figure 87. Middle East, Africa and Latin America Poloxamer Revenue Market Share by Type (2019-2030)
 Figure 88. Middle East, Africa and Latin America Poloxamer Sales Market Share by Application (2019-2030)
 Figure 89. Middle East, Africa and Latin America Poloxamer Revenue Market Share by Application (2019-2030)
 Figure 90. Middle East, Africa and Latin America Poloxamer Revenue Share by Country (2019-2030)
 Figure 91. Middle East, Africa and Latin America Poloxamer Sales Share by Country (2019-2030)
 Figure 92. Brazil Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 93. Mexico Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 94. Turkey Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 95. Israel Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 96. GCC Countries Poloxamer Revenue (2019-2030) & (US$ Million)
 Figure 97. Poloxamer Value Chain
 Figure 98. Poloxamer Production Process
 Figure 99. Channels of Distribution (Direct Vs Distribution)
 Figure 100. Bottom-up and Top-down Approaches for This Report
 Figure 101. Data Triangulation
 Figure 102. Key Executives Interviewed